![[Galaxy Unpacked 2026] A First Look at the Galaxy S26 Series: Samsung’...](/Updates/index/HTML_Images/NewsEN_MostPopular_img_2.jpg?1110810383)
403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Ventripoint Diagnostics Ltd
(MENAFN- Baystreet) 12:52 PM EST - Ventripoint Diagnostics Ltd: Announced, in response to significant investor interest, it will double its previously announced non-brokered private placement from $500,000 to $1,000,000 subject to TSX Venture Exchange approval. Each Unit will be comprised of one common share of the Corporation, and one common share purchase warrant. Each whole Warrant will entitle the holder thereof to purchase one Common Share at a price of $0.13 for a period of 24 months from the closing of the Offering. Ventripoint Diagnostics Ltd
shares V are trading unchanged at $0.13.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment